尿液可替宁与自我报告吸烟及慢性肾脏病风险的比较
基于PREVEND前瞻性研究4333名基线无CKD的参与者,比较自我报告与尿液可替宁评估的吸烟状态与CKD风险的关联。中位随访7.0年,593例发生CKD。自我报告当前吸烟与CKD风险增加相关但依赖尿白蛋白排泄,而尿液可替宁评估的当前吸烟与CKD风险增加独立于尿白蛋白排泄。
要点
- 自我报告当前吸烟与CKD风险增加相关,但进一步调整UAE后关联减弱。
- 尿液可替宁评估的当前吸烟与CKD风险增加独立于UAE。
- 尿液可替宁评估吸烟状态可能是比自我报告更可靠的CKD风险指标。
核心结论
- 自我报告当前吸烟与CKD风险增加相关,但依赖尿白蛋白排泄。
- 尿液可替宁评估的当前吸烟与CKD风险增加独立于尿白蛋白排泄。
- 尿液可替宁评估的吸烟状态可能是比自我报告更可靠的CKD风险指标。
研究设计与样本
- 基于PREVEND前瞻性研究,纳入4333名基线无CKD史的参与者(平均年龄52岁)。
- 基线时通过自我报告和尿液可替宁评估吸烟状态,并按可比界值分类。
- 中位随访7.0年,记录593例CKD事件。
主要发现
- 自我报告和可替宁评估的当前吸烟者比例分别为27.5%和24.0%。
- 调整既定危险因素后,自我报告既往、轻度当前和重度当前吸烟者相比从不吸烟者的CKD风险HR(95%CI)分别为1.17(0.95-1.44)、1.48(1.10-2.00)和1.48(1.14-1.93)。
- 进一步调整UAE后,上述HR(95%CI)分别为1.07(0.87-1.32)、1.26(0.93-1.70)和1.20(0.93-1.57)。
- 尿液可替宁评估的相应HR(95%CI)在调整既定危险因素加UAE后分别为0.81(0.52-1.25)、1.17(0.92-1.49)和1.32(1.02-1.71)。
临床怎么用
- 在评估CKD风险时,尿液可替宁评估的吸烟状态可能提供独立于尿白蛋白排泄的风险信息。
- 对于自我报告吸烟者,需考虑尿白蛋白排泄对CKD风险关联的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND HYPOTHESIS: Evidence on the role of smoking in the development of chronic kidney disease (CKD) has mostly relied on self-reported smoking status. We aimed to compare the associations of smoking status as assessed by self-reports and urine cotinine with CKD risk. METHODS: Using the PREVEND prospective study, smoking status was assessed at baseline using self-reports and urine cotinine in 4333 participants (mean age, 52 years) without a history of CKD at baseline. Participants were classified as never, former, light current, and heavy current smokers according to self-reports and comparable cutoffs for urine cotinine. Hazard ratios (HRs) with 95% confidence intervals (CIs) were estimated for CKD. RESULTS: The percentages of self-reported and cotinine-assessed current smokers were 27.5% and 24.0%, respectively. During a median follow-up of 7.0 years, 593 cases of CKD were recorded. In analyses adjusted for established risk factors, the HRs (95% CI) of CKD for self-reported former, light current, and heavy current smokers compared with never smokers were 1.17 (0.95-1.44), 1.48 (1.10-2.00), and 1.48 (1.14-1.93), respectively. On further adjustment for urinary albumin excretion (UAE), the HRs (95% CI) were 1.07 (0.87-1.32), 1.26 (0.93-1.70), and 1.20 (0.93-1.57), respectively. For urine cotinine-assessed smoking status, the corresponding HRs (95% CI) were 0.81 (0.52-1.25), 1.17 (0.92-1.49), and 1.32 (1.02-1.71), respectively, in analyses adjusted for established risk factors plus UAE. CONCLUSION: Self-reported current smoking is associated with increased CKD risk, but dependent on UAE. The association between urine cotinine-assessed current smoking and increased CKD risk is independent of UAE. Urine cotinine-assessed smoking status may be a more reliable risk indicator for CKD incidence than self-reported smoking status.
引用
- Kunutsor SK, Dey RS, Touw DJ, et al. Urine cotinine versus self-reported smoking and the risk of chronic kidney disease. Nephrol Dial Transplant. 2024. PMID: 38402463. doi:10.1093/ndt/gfae054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。